Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)

计划入组 78 人 · 首次发布于 2026 年 2 月 12 日

A Study of KL130008 in Adults With Severe Alopecia Areata

计划入组 114 人 · 首次发布于 2022 年 8 月 11 日

Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata

计划入组 30 人 · 首次发布于 2022 年 5 月 10 日

Ritlecitinib(Litfulo)

C₁₅H₁₉N₅O · Rx

Alopecia Areata(Alys)

anti-inflammatory (alopecia areata/AIDEN)

Zura Bio

United States

Arcutis Biotherapeutics

United States

NATIONAL INSTITUTE OF DISEASES OF THE CHEST AND HOSPITAL

Bangladesh

Sun Pharma Launches Deuruxolitinib for Severe Alopecia Areata in US Market

Pfizer's Litfulo Becomes First NHS-Approved Treatment for Severe Alopecia Areata

Topical Immunotherapy Shows Promise for Severe Alopecia Areata Despite Variable Response Rates